CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 284,881	$ 303,242
Patient accounts receivable	319,639	296,075
Prepaid expenses	17,410	13,072
Other current assets	12,034	19,694
Total current assets	633,964	632,083
Property and equipment, net of accumulated depreciation of $103,758 and $100,890	40,186	42,108
Operating lease right of use assets	80,905	81,500
Goodwill	1,213,888	1,213,888
Intangible assets, net of accumulated amortization of $19,949 and $18,787	80,199	81,155
Other assets	135,432	87,980
Total assets	2,184,574	2,138,714
Current liabilities:
Accounts payable	28,705	39,956
Payroll and employee benefits	131,722	151,995
Accrued expenses	162,180	152,564
Termination fee paid by UnitedHealth Group	106,000	106,000
Current portion of long-term obligations	37,579	37,968
Current portion of operating lease liabilities	25,845	25,909
Total current liabilities	492,031	514,392
Long-term obligations, less current portion	332,947	339,313
Operating lease liabilities, less current portion	55,642	56,111
Deferred income tax liabilities	58,032	48,051
Other long-term obligations	848	882
Total liabilities	939,500	958,749
Commitments and Contingencies—Note 7
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 38,381,255 and 38,307,521 shares issued; 32,818,871 and 32,776,148 shares outstanding	38	38
Additional paid-in capital	825,138	818,201
Treasury stock, at cost, 5,562,384 and 5,531,373 shares of common stock	(477,718)	(474,854)
Retained earnings	852,168	791,156
Total Amedisys, Inc. stockholders’ equity	1,199,626	1,134,541
Noncontrolling interests	45,448	45,424
Total equity	1,245,074	1,179,965
Total liabilities and equity	$ 2,184,574	$ 2,138,714